Literature DB >> 21134857

Chemical and biological investigations of Delonix regia (Bojer ex Hook.) Raf.

Israt Jahan1, Mohammad S Rahman, Mohammed Z Rahman, Mohammad A Kaisar, Mohammad S Islam, Abdul Wahab, Mohammad A Rashid.   

Abstract

In this study, five compounds, lupeol (1), epilupeol (2), β-sitosterol (3), stigmasterol (4) and p-methoxybenzaldehyde (5) were isolated from the petroleum ether and dichloromethane fractions of a methanolic extract of the stem bark of Delonix regia. Antimicrobial screening of the different extracts (15 μg mm-2) was conducted by the disc diffusion method. The zones of inhibition demonstrated by the petroleum ether, carbon tetrachloride and dichloromethane fractions ranged from 9-14 mm, 11-13 mm and 9-20 mm, respectively, compared to kanamycin standard with the zone of inhibition of 20-25 mm. In brine shrimp lethality bioassay, the carbon tetrachloride soluble materials demonstrated the highest toxicity with LC50 of 0.83 μg mL-1, while petroleum ether and dichloromethane soluble partitionates of the methanolic extract revealed LC50 of 14.94 and 3.29 μg mL-1, respectively, in comparison with standard vincristine sulphate with LC50 of 0.812 μg mL-1. This is the first report on compounds separation from D. regia, their antimicrobial activity and cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134857     DOI: 10.2478/v10007-010-0018-7

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  2 in total

Review 1.  Ethnomedicinal and phytochemical review of Pakistani medicinal plants used as antibacterial agents against Escherichia coli.

Authors:  Muhammad Adnan; Roqaia Bibi; Sakina Mussarat; Akash Tariq; Zabta Khan Shinwari
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-08-19       Impact factor: 3.944

2.  Delonix regia Leaf Extract (DRLE): A Potential Therapeutic Agent for Cardioprotection.

Authors:  Lung-Shuo Wang; Chun-Ting Lee; Wei-Lieh Su; Shih-Che Huang; Shu-Chi Wang
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.